Literature DB >> 27477135

Further Investigation of Ketamine.

Robert Freedman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27477135     DOI： 10.1176/appi.ajp.2016.16050581

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  3 in total

Review 1.  Investigational drugs in recent clinical trials for treatment-resistant depression.

Authors:  Ricardo P Garay; Carlos A Zarate; Thomas Charpeaud; Leslie Citrome; Christoph U Correll; Ahcène Hameg; Pierre-Michel Llorca
Journal:  Expert Rev Neurother       Date:  2017-01-29       Impact factor: 4.618

Review 2.  Addictive potential of novel treatments for refractory depression and anxiety.

Authors:  Dusan Kolar
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-12       Impact factor: 2.570

3.  Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions.

Authors:  Danielle M Gerhard; Ronald S Duman
Journal:  Curr Behav Neurosci Rep       Date:  2018-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.